Dalton Tx raises £4 million in seed funding to enhance drug discovery technology. The funding will help build their AI-driven platform for scientific collaboration.

Sep 23, 2025•4 days ago

Amount Raised

£4 Million

Round Type

seed

LondonArtificial IntelligenceBiotechnology

Description

Dalton Tx has secured £4 million in seed financing to develop their advanced drug discovery platform. By integrating machine learning with scientific workflows, their technology aims to transform research capabilities. Founded by experts from academia and industry, Dalton Tx focuses on adaptive AI solutions. This funding will support their growth in addressing complex drug development challenges.

Company Information

Company

Dalton Tx

Location

London, England, United Kingdom

About

Dalton Tx is a UK-based technology company focused on transforming drug discovery through adaptive, AI-enabled platforms. Founded by experts in drug discovery, machine learning, and software engineering, the company aims to integrate advanced AI capabilities directly into scientific workflows. Its platform is designed for both small molecules and biologics, enabling collaborative intelligence among scientists. Dalton Tx addresses high-impact challenges in drug R&D, facilitating faster and more effective medicine discovery.

Dalton Tx raises £4 million in seed funding to enhance drug discovery technology. The funding will help build their AI-driven platform for scientific collaboration.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information